Structure Therapeutics Stock Forward View - Simple Exponential Smoothing
| GPCR Stock | 58.20 -0.02 -0.03% |
Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.31 | EPS Estimate Current Year -1.44 | EPS Estimate Next Year -2.13 | Wall Street Target Price 108.9333 | EPS Estimate Current Quarter -0.37 |
This section relates Structure Therapeutics American headline activity to recent price behavior and peer context. Options positioning and short interest are used here to outline sentiment for Structure Therapeutics.
Structure Therapeutics Short Interest Summary
Structure Therapeutics' short interest measures the total number of shares sold short but not yet covered. Rising short interest can signal growing bearish sentiment among institutional and retail investors.
200 Day MA 39.2023 | Short Percent 0.0931 | Short Ratio 4.14 | Shares Short Prior Month 5.1 M | 50 Day MA 74.0083 |
Structure RSI Snapshot
The Simple Exponential Smoothing forecasted value of Structure Therapeutics American on the next trading day is expected to be 58.20 with a mean absolute deviation of 2.16 and the sum of the absolute errors of 129.76.Structure Therapeutics Hype vs Price Pattern
Public perception of Structure Therapeutics American - captured through news and social media signals - can drive Structure Therapeutics' stock price away from intrinsic value for extended periods. Analyzing these biases provides an edge for contrarian investors.
When Structure Therapeutics' market sentiment is overly bullish relative to its actual financial performance, the stock may be overvalued. Excessively negative sentiment can create buying opportunities for patient investors.
Structure Therapeutics Implied Volatility | 1.53 |
High implied volatility in Structure Therapeutics' options signals that the market anticipates large price swings in Structure Therapeutics stock. Conversely, low implied volatility indicates that investors expect relatively stable price action.
The Simple Exponential Smoothing forecasted value of Structure Therapeutics American on the next trading day is expected to be 58.20 with a mean absolute deviation of 2.16 and the sum of the absolute errors of 129.76.Structure Therapeutics after-hype prediction price | $ 57.02 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Structure | Build AI portfolio with Structure Stock |
Rule 16 for the current Structure contract - Pricing Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.0956% for the 2026-04-17 options. This estimate is a volatility reference; at $ 58.2, it implies a move of about $ 0.0557 per day.
Structure Options Open Interest - 2026-04-17
Open interest on Structure Therapeutics summarizes how many option contracts remain open and helps frame liquidity and positioning.
Structure Therapeutics Additional Predictive Modules
Most predictive techniques to examine Structure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Structure using various technical indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Structure Therapeutics Simple Exponential Smoothing Price Forecast For the 12th of March 2026
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Structure Therapeutics American on the next trading day is expected to be 58.20 with a mean absolute deviation of 2.16 , mean absolute percentage error of 8.44 , and the sum of the absolute errors of 129.76 .Please note that although there have been many attempts to predict Structure Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Structure Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Structure Therapeutics Stock Forecast Pattern
| Backtest Structure Therapeutics | Structure Therapeutics Price Prediction | Research Analysis |
Structure Therapeutics Forecasted Value
This next-day forecast for Structure Therapeutics American uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Structure Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Structure Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.4062 |
| Bias | Arithmetic mean of the errors | 0.154 |
| MAD | Mean absolute deviation | 2.1627 |
| MAPE | Mean absolute percentage error | 0.03 |
| SAE | Sum of the absolute errors | 129.76 |
The concept of mean reversion suggests that Structure Therapeutics' price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
Structure Therapeutics After-Hype Price Density Analysis
The price distribution graph for Structure Therapeutics visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of Structure Therapeutics' outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
Structure Therapeutics Estimiated After-Hype Price Volatility
The downside and upside margins for Structure Therapeutics after major news events are estimated from historical precedent. Structure Therapeutics' after-hype downside and upside margins for the prediction period are 52.99 and 61.05, respectively. This approach captures the empirical distribution of Structure Therapeutics' short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to Structure Therapeutics American assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Structure Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Structure Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Structure Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Structure Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 4.03 | 0.98 | 0.05 | 8 Events | 8 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
58.20 | 57.02 | 1.79 |
|
Structure Therapeutics Hype Timeline
Structure Therapeutics is currently traded for 58.20. The company has historical hype elasticity of -0.98, and average elasticity to hype of competition of -0.05. Structure is forecasted to decline in value after the next headline, with the price expected to drop to 57.02. The average volatility of media hype impact on the company price is about 66.07%. The price decrease on the next news is expected to be -1.79%, whereas the daily expected return is currently at -0.16%. The volatility of related hype on Structure Therapeutics is about 1271.29%, with the expected price after the next announcement by competition of 58.15. About 96.0% of the company shares are owned by institutional investors. The book value of Structure Therapeutics was currently reported as 21.41. The company recorded a loss per share of 2.4. Structure Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in 8 days. Use Historical Fundamental Analysis of Structure Therapeutics to cross-verify projections for Structure Therapeutics. The historical view provides additional context.Structure Therapeutics Related Hype Analysis
The relationship between Structure Therapeutics and its sector peers means that news affecting one company often reverberates across Structure Therapeutics' competitive landscape. Tracking peer hype helps investors anticipate Structure Therapeutics's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EWTX | Edgewise Therapeutics | -1.01 | 9 per month | 3.94 | 0.09 | 7.54 | -5.20 | 38.85 | |
| VRDN | Viridian Therapeutics | -0.75 | 11 per month | 0.00 | -0.03 | 4.62 | -3.95 | 10.53 | |
| QURE | Uniqure NV | -0.09 | 9 per month | 0.00 | -0.003 | 12.55 | -10.75 | 45.37 | |
| OCUL | Ocular Therapeutix | -0.18 | 10 per month | 0.00 | -0.0037 | 8.46 | -6.99 | 49.34 | |
| NUVB | Nuvation Bio | 0.24 | 8 per month | 0.00 | -0.14 | 5.48 | -5.53 | 32.79 | |
| GLPG | Galapagos NV ADR | 0.01 | 4 per month | 1.34 | 0.06 | 2.21 | -1.85 | 6.36 | |
| MESO | Mesoblast | -0.36 | 10 per month | 0.00 | -0.01 | 5.49 | -6.32 | 16.58 | |
| LQDA | Liquidia Technologies | -0.78 | 8 per month | 4.21 | 0.07 | 5.47 | -6.46 | 24.32 | |
| CLDX | Celldex Therapeutics | -0.35 | 9 per month | 2.71 | 0.06 | 5.65 | -5.57 | 27.61 | |
| ABCL | Abcellera Biologics | 0.10 | 10 per month | 4.17 | 0.03 | 8.41 | -6.22 | 28.69 |
Other Forecasting Options for Structure Therapeutics
Whether a novice or experienced investor, anyone considering Structure needs to understand the dynamics of Structure Therapeutics' price movement. Price charts for Structure Stock contain a significant amount of noise that can distort investment decisions.Structure Therapeutics Related Equities
The following equities are related to Structure Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Structure Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Structure Therapeutics Market Strength Events
Analyzing market strength indicators for Structure Therapeutics enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Structure Therapeutics American.
Structure Therapeutics Risk Indicators
Identifying and analyzing Structure Therapeutics' key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with Structure Therapeutics' and decide how to manage it.
| Mean Deviation | 4.9 | |||
| Semi Deviation | 3.03 | |||
| Standard Deviation | 13.25 | |||
| Variance | 175.61 | |||
| Downside Variance | 13.4 | |||
| Semi Variance | 9.19 | |||
| Expected Short fall | -6.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Structure Therapeutics
Coverage intensity for Structure Therapeutics American matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Structure Therapeutics Short Properties
Short sentiment tied to Structure Therapeutics American matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 59.2 M | |
| Cash And Short Term Investments | 1.4 B |
Additional Tools for Structure Stock Analysis
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |